Opinion

Video

Unmet Needs in Current IgAN Treatment

Key Takeaways

  • Biomarkers, including genetic mutations and protein expressions, are vital for predicting disease progression and treatment response.
  • Advanced diagnostic techniques are essential for identifying molecular and cellular indicators that inform patient prognosis.
SHOW MORE

Panelists discuss how the current treatment landscape for IgA nephropathy presents significant unmet needs, particularly in addressing the underlying causes of the disease and improving patient outcomes.

  1. What do you believe are the most significant unmet needs in the current treatment landscape for IgA nephropathy?
Related Videos
3 experts are featured in this series.
Pranav Garimella, MBBS, MPH | Credit: GlobalNewsWire
3 experts are featured in this series.
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.